Skip to main content
. 2022 Apr 5;12(2):231–241. doi: 10.5455/OVJ.2022.v12.i2.11

Table 1. Clinical scoring system used to determine the individualized activity of radioiodine to be administered (Mooney, 1994).

Score Severity of clinical signs Serum total T4 concentration (nmol/l) Size of goiter Total score and recommended activity
1 Mild < 80 Palpable with difficulty <9: <120 MBq
2 Mild to moderate <100 1.0 × 0.5 cm 9–12: 120–150 MBq
3 Moderate 100–150 1.5 × 0.5 cm >12: 150–180 MBq
4 Moderate to severe 150–400 >1.5 × 0.5 cm If bilateral disease, the higher end of the dose interval was used
5 Severe >400 Visible to naked eye